1990
DOI: 10.1161/01.cir.82.4.1279
|View full text |Cite
|
Sign up to set email alerts
|

Incidence and prognosis of secondary ventricular fibrillation in acute myocardial infarction. Evidence for a protective effect of thrombolytic therapy. GISSI Investigators.

Abstract: (Circulation 1990;82:1279-1288

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
18
0

Year Published

1994
1994
2015
2015

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 64 publications
(18 citation statements)
references
References 47 publications
0
18
0
Order By: Relevance
“…However, reperfusion therapy by thrombolytic therapy has been shown to improve survival when administered up to 12 hours after infarct onset,'4 and it has been suggested that this benefit occurs via changes in ventricular diastolic function and healing, and possibly via a decrease in susceptibility to serious arrhythmias. [4][5][6] Nearly immediate improvement in diastolic function with very delayed reperfusion has been demonstrated in animal models of infarction,29 and reduction in ventricular tachycardias by streptokinase therapy was observed in GISSI I.6 Assuming this paradigm to be correct, then any benefit from rescue angioplasty would need to result from angioplasty affecting a higher incidence of, or earlier, reperfusion than might be expected by delayed lytic-mediated reperfusion13 and not be offset by any adverse effect of the angioplasty procedure itself." Data from this study and its much smaller predecessor,19 taken together, strongly suggest that rescue angioplasty may exert a benefit for selected patients and that the responsible mechanism(s) likely involve improved diastolic function and/or systolic function under stress.…”
Section: Discussionmentioning
confidence: 99%
“…However, reperfusion therapy by thrombolytic therapy has been shown to improve survival when administered up to 12 hours after infarct onset,'4 and it has been suggested that this benefit occurs via changes in ventricular diastolic function and healing, and possibly via a decrease in susceptibility to serious arrhythmias. [4][5][6] Nearly immediate improvement in diastolic function with very delayed reperfusion has been demonstrated in animal models of infarction,29 and reduction in ventricular tachycardias by streptokinase therapy was observed in GISSI I.6 Assuming this paradigm to be correct, then any benefit from rescue angioplasty would need to result from angioplasty affecting a higher incidence of, or earlier, reperfusion than might be expected by delayed lytic-mediated reperfusion13 and not be offset by any adverse effect of the angioplasty procedure itself." Data from this study and its much smaller predecessor,19 taken together, strongly suggest that rescue angioplasty may exert a benefit for selected patients and that the responsible mechanism(s) likely involve improved diastolic function and/or systolic function under stress.…”
Section: Discussionmentioning
confidence: 99%
“…The episodes of VF observed in the CL may be related to injury secondary to the faster reperfusion obtained with PCI. The link between VF development and the rate of restoration of blood flow after coronary occlusion was previously described in several studies based on experimental models (14)(15)(16)(17)(18).…”
Section: Vfmentioning
confidence: 99%
“…This percentage may vary according to the agent and dosing regimen used [3][4][5]. Patients with failed thrombolytic therapy are at higher risk due to left ventricular dysfunction, life-threatening arrhythmias and death [6][7][8]. Although it may seem obvious that rescue (salvage) percutaneous transluminal coronary angioplasty (PTCA) of the IRA would benefit the prognosis of these patients, its clinical value still remains controversial [9][10][11][12].…”
mentioning
confidence: 99%